Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue
+4.97%
EPS
+731.9%
Free cash flow
+255.6%
Total debt
−9.48%

Quarter to September 2026, against a year earlier

25.57 0.93 −3.51%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
21.3×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) P/E ratio

Alert me on P/E ratio

Baxter International Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 190× (September 2024) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 7.4× —
FY2022 0.0× —
FY2021 33.5× (9.74%)
FY2020 37.1× (10.26%)
FY2019 41.4× 91.19%
FY2018 21.7× (57.45%)
FY2017 50.9× 937.42%
FY2016 4.9× (77.22%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 190×
Ten-year median 16.4×
Current reading's percentile 24

P/E ratio against peers

Company P/E ratio
RGEN Repligen Corporation compare n/m
BAX Baxter International Inc. n/m
BLCO Bausch + Lomb Corporation compare n/m
COO The Cooper Companies, Inc. compare 21.7×
ALGN Align Technology, Inc. compare 23.1×
AVTR Avantor, Inc. compare 30.3×
ATR AptarGroup, Inc. compare 34.6×
WST West Pharmaceutical Services, Inc. compare 43.8×
SOLV Solventum Corporation compare 97.3×
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BAX